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Neuroblastoma in monozygotic twins is rarely reported but of
interest because of the insights it gives regarding tumorigenesis
and/or metastasis. Previously, only 6 sets of monozygotic twins
concordant for neuroblastoma have been described and none of
concordant dizygotic twins (Boyd and Schofield, 1995; Kushner
and Helson, 1985; Mancini et al, 1982). This relative absence,
together with the paucity of constitutional karyotype abnormali-
ties, suggests that there is not, in general, a strong constitutional
genetic component for neuroblastoma (Buckley et al, 1996). Rare
descriptions of constitutional rearrangements involving regions
1p36 and 17q11-ter have confirmed the importance of these
regions in the aetiology of neuroblastoma (Biegel et al, 1993;
Laureys et al, 1990; Laureys et al, 1995a; Mead and Cowell,
1995). The general lack of predisposing constitutional factors
coupled with the relatively high incidence of blood-borne
metastatic disease in congenital neuroblastoma, raises the
intriguing possibility of twin-to-twin metastasis in concordant
twins. This pattern of transplacental dissemination has been
proven in cases of infant leukaemia, but never previously reported
in a solid tumour. We report a further case of twins concordant for
neuroblastoma and we propose transplacental metastatic spread as
the most likely mechanism of shared pathology. 
MATERIALS AND METHODS 
G banding of metaphases derived from peripheral blood samples
were prepared using standard techniques. A total of 52 metaphase
cells were examined from twin 1, and 49 from twin 2. 
Slides for fluorescence in situ hybridization (FISH) were
prepared from fixed cell samples and pre-treated using standard
techniques. Whole chromosome paints (WCPs) for chromosomes
1 and 3 (Cambio, Cambridge, UK) and probes for MYCN, distal
chromosome 17q, the telomeric region of 1q (VYSIS Inc, Illinois,
USA), the sub-telomeric region of 1q (1q44-qter) (Appligene
Oncor, Co.  Durham, UK) and the p58 cosmid probe that maps to
1p36 (Appligene Oncor, Co. Durham, UK) were prepared and
hybridized according to the manufacturers’ instructions. For
analysis by WCPs of chromosomes 1 and 3 rearrangements, 43
metaphase cells were examined from twin 1 and 47 from twin 2.
For the locus-specific probes for chromosome 1, 87 metaphase
cells were examined from twin 1, and 53 from twin 2. 
CASE HISTORY 
The patients were baby girls born following a healthy pregnancy at
37 weeks’ gestation to unrelated parents who had 3 older, healthy
children. At delivery there was a single placenta. At 3 weeks of
age, twin 1 presented with abdominal swelling, hepatomegaly, a
left suprarenal mass, 10% infiltration of small round cells in the
bone marrow and raised levels of urinary catecholamines and
serum LDH and NSE. A biopsy of the adrenal tumour gave a histo-
logical diagnosis of neuroblastoma. 
In view of the previous reports of concordance for neuro-
blastoma in monozygotic twins, it was decided that twin 2 would
be screened by assessment of urinary catecholamines as well as by
abdominal ultrasound scan every 3 months. At 6 months of age, a
3.5 × 5.0 cm right adrenal mass and 3 nodular hepatic lesions were
found, although catecholamine levels were normal and there was
no evidence of lesions at other metastatic sites. An open biopsy of
the adrenal tumour gave a diagnosis of neuroblastoma, which was
histologically indistinguishable from that of her sister. 
Twin 1 presented with a rapidly growing tumour causing
cardiorespiratory failure and requiring ventilatory and inotropic
support until there was tumour shrinkage. Both twins had been
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cyclophosphamide, etoposide and carboplatin alternating with
identical courses substituting cisplatin for carboplatin), surgery of
the primary tumour, consolidation of remission with high-dose
melphalan and continuation treatment with 13-cis retinoic acid. At
the time of writing both twins remain well and disease free 18 and
12 months, respectively, following completion of treatment. 
RESULTS 
Only a small needle tumour biopsy was available for twin 1.
Interphase FISH on touch imprints from this tumour revealed
multiple copies of the MYCN oncogene and deletion of chromo-
some region 1p36. Twin 2’s tumour was investigated by both inter-
phase and metaphase FISH. Interphase showed multiple copies of
MYCN and deletion of 1p36. G banding of metaphases revealed
an apparently normal karyotype, but addition of locus-specific
flourescent probes demonstrated amplification of MYCN on
double minutes, loss of chromosome region 1p36 (up to 8 copies
of the chromosome 1 centromeric region but only ever 1 copy of
1p36), and gain of distal chromosome 17q (consistently 2 copies
of 17 centromere but mostly 3 copies of both ERBB2 and MPO
probes). Gain at 17q and 2p23-24 was confirmed for this tumour
by comparative genomic hybridization analysis. Constitutional
DNA from both twins was used in microsatellite analysis of highly
polymorphic CA repeats and confirmed monozygosity. 
Constitutional karyotyping of twins 1 and 2 was performed at
10 and 4 months, respectively, following high-dose melphalan
treatment. There were abnormalities of chromosome 1 and/or
chromosome 3 in 3 out of 52 (5.7%) of cells from twin 1 (Table 1).
The complex internal rearrangement of chromosome 1, in one cell
only, appeared to have resulted from the loss of the p arm segment
from band 1p13.1→ 1p36, followed by duplication of the q arm
segment from band q21→ q44, followed by the pericentric inver-
sion and insertion of the duplicated segment into the region of
deletion at 1p13.1→ 1p36. A paracentric inversion of chromosome
3 between bands p23 and p26 was detected in the same cell
containing the derivative chromosome 1 and in a further 2
metaphase cells, which appeared to have normal copies of chro-
mosome 1. FISH analysis with WCPs revealed 2 out of 43 (4.6%)
metaphase cells with abnormal copies of 1 chromosome 1. In both
cells, the breakpoint on chromosome 1 appeared to be at 1p13.1,
with the suggestion that a translocation partner was involved,
possibly chromosome 17. However this could not be verified with
the subsequent use of a WCP for 17. A subtelomeric probe for
chromosome 1q disclosed deletions of this region in 24 out of 111
(21.6%) metaphase cells. Later investigation with a probe for the
telomeric region of 1q demonstrated the presence of telomeric
sequences in all cells examined. There was no indication of dele-
tion of 1p36 using the p58 cosmid probe in all 111 cells examined.
To exclude the presence of minimal residual disease as an explana-
tion of the constitutional abnormalities, a MYCN locus-specific
probe was applied to an aliquot of the same fixed cell suspension.
No abnormalities of MYCN were found in any of 60 cells
examined, excluding the possibility of tumour cell contamination. 
No evidence of chromosomal abnormality, both by karyotype
and FISH analysis, was found in the metaphase cells examined
from twin 2. Skin biopsy samples were not available from the
twins for further constitutional analysis. Constitutional karyo-
typing of both parents was normal. 
DISCUSSION 
We have described a pair of monozygotic twins concordant for
neuroblastoma. There was no family history of cancer and there
were 3 healthy older siblings. Pathological and molecular analysis
of the tumours found them to be indistinguishable. 
Three hypotheses exist for the concordance of neuroblastoma in
this case. Firstly, it could represent separate de novo genetic events
occurring independently of each other. The rarity of neuroblas-
toma and the genetic, clinical and morphological similarity
between the tumours makes this possibility extremely unlikely.
Secondly, a shared genetic predisposition may have initiated the
process of tumorigenesis culminating in 2 independently derived
tumours. If this were true, a new germline mutation would be the
most likely source given the absence of a family history and the 3
healthy older siblings. Constitutional abnormalities have been
found, but only in twin 1, and only in a proportion of haemato-
poietic cells. Other cell types were not available for confirmation
of the cytogenetic findings. 
The low level of abnormal cells found in twin 1, suggests either
a low-level constitutional mosaicism for abnormalities predis-
posing her to develop neuroblastoma, or a post-treatment exposure
of underlying chromosome instability that had primed her to
develop the disease. However, 3 of the 4 rearranged regions
discovered in twin 1 (1p, 17q and 3p) involve regions known to be
of importance in neuroblastoma tumorigenesis, making random
secondary changes extremely unlikely. In total, 3 out of 95 (3.1%)
of cells showed abnormalities of chromosome 1p13.1, the region
of the N-Ras1 oncogene implicated in neuroblastoma tumori-
genesis. This region has previously been reported as a fragile site
in lymphocytes studied from patients with neuroblastoma
(Rudolph et al, 1988; Vernole et al, 1989). Moreover, a survey of
126 neuroblastoma karyotypes revealed breakpoints at 1p13–21 to
be the most common finding (Mertens et al, 1997). The fragile site
fra(1)(p13.1) may contribute to neuroblastoma tumorigenesis
through secondary effects on 1p36, a region undergoing allele loss
in a high proportion of neuroblastomas including those in these 2
children (Brodeur et al, 1981; Gilbert et al, 1982; Schleiermacher
et al, 1994; Van Roy et al, 1997). This was the case with both the
abnormalities involving 1p detected in twin 1’s constitutional
samples where both chromosome abnormalities involved the loss
of 1p distal to 1p13.1. A further constitutional change involving
t(1:17)(p34–36:q11. 2–21) has been described in at least 4 
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Table I Constitutional cytogenetic and FISH data for Twin 1 
GTG-band analysis Number/% of metaphase cells
abnormal 
46,XX, inv(3)(p23p26) 2(3.8%) 
46,XX, der(1)del(1)(p36 p13.1)dup(1)(q21q44) 
invinsdup(1)(p13.1q21), inv(3)(p23p26) 1 (1.9%) 
46,XX 49 (94.3%) 
FISH analysis Number/% of metaphase cells
abnormal 
46,XX.ish t(1;?17)(p13.1;?q25)(wcp1) 1 (2.3%) 
46,XX.ish del(1)(p13.1p36)(wcp1) 1 (2.3%) 
46,XX.ish (wcp1) 41 (95.4%) 
46,XX.ish del(1)(q44q44)(D1S69-) 24 (21.6%) 
46,XX.ish (D1S69) 87 (78.4%) neuroblastoma patients (Laureys et al, 1990; Laureys et al, 1995b;
Mitchell et al, 1996; Van Roy et al, 1997). The regions involved in
the abnormal cells from twin 1, at 1p13.1 and 17q25, are novel
translocation breakpoints and suggest further regions of instability
on both chromosomes 1 and 17, possibly contributing to the key
stages in neuroblastoma development of loss of 1p36 and gain of
distal 17q relative to proximal 17q. Abnormalities of chromosome
3p in neuroblastomas have predominantly been reported as dele-
tions (Breen et al, 2000; Ejeskar et al, 1998; Hallstensson et al,
1997). The inv(3)(p23p26) seen in the metaphase cells from twin 1
is located in the consensus region of deletion in neuroblastoma
tumours 3p25.3-3p14.3 (Ejeskar et al, 1998), and therefore might
be of some significance. Region 3p is frequently involved in
deletions and/or rearrangements in neuroblastoma tumours
(Hallstensson et al, 1997). Overall del(3p) is the second most
frequently deleted region in this tumour type following del(1p36).
A novel region of deletion in the subtelomeric region of chromo-
some 1 at q44, found in a high proportion (21.6%) of metaphase
cells, suggests that this may be a further region of constitutional
instability previously unreported in neuroblastoma.
It seems unlikely that twin 2 actually shared the constitutional
abnormalities of twin 1, but we were unable to detect them due to
sampling error. More than 80 metaphases from twin 2 were
analyzed by both G banding and FISH studies using chromosome
1 and 3 probes, and no abnormalities were seen. Therefore, we
favour the hypothesis that the chromosomal rearrangements
observed represent mosaicism in twin 1 or a genomic instability
predisposing to neuroblastoma and acquired in utero following
blastocyst division.
A constitutional abnormality present in twin 1 but absent in twin
2 therefore supports a third hypothesis, namely that there was
transplacental metastasis of tumour from twin 1 to twin 2. Of note
is the finding that twin 2 developed neuroblastoma 6 months
following her sibling and the tumour was detected at an early
stage, prior to any symptoms developing. This timing would be
consistent with micrometastatic deposits of tumour having
implanted in twin 2 by the time of delivery. If true, the occurrence
of disease in twin 2 in adrenal gland and liver indicates metastasis
to adrenal gland, a phenomenon that is not generally recognized in
neuroblastoma but is one possible explanation for the rarely
described phenomenon of bilateral neuroblastoma. 
The early pre-symptomatic detection of tumour in twin 2 illus-
trates two points. Firstly, although both twins have attained
complete remission and although there is no evidence that a large
biologically unfavorable tumour is less likely to shrink than a
smaller version of the same tumour, twin 2 was not in danger of the
severe morbidity associated with the rapidly expanding abdominal
mass that her sister had. Waiting until the disease presented itself
through the development of a symptomatic mass could have
resulted in markedly increased morbidity or mortality related to
tumour size. Secondly, the relatively long interval between the
development of the 2 tumours indicates that a prolonged period of
surveillance may be needed to identify tumours at an early stage. 
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